Predictors of Left Ventricular Function Improvement in Patients Prescribed Sacubitril/Valsartan in a Tertiary-Care Community-Based Heart Failure Cohort

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Safety of Initiation of Sacubitril/Valsartan in ICU Patients With Advanced Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Discontinuation Rates of Sacubitril/Valsartan at a Large, Community-Based Heart Failure Program: Demographic, Clinical and Payer Origin Associations

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Sacubitril-Valsartan Initiation Post-Left Ventricular Assist Device Is Safe and Effective

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Tolerability, Safety, and Hemodynamics of Sacubitril-Valsartan in Acutely Decompensated Heart Failure Patients With Cardiogenic Shock

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy